Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100OU1N
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥3.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥354m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥439m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥440m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥255m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥28.2bnat 2022-06-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥21.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.482021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.422021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥385m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥374m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥468m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥241m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥36m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥60m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥303m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2021-04-01 → 2021-06-30¥166m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥164m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥162m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥16m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-06-30¥71m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥390m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥228m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥161m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥21m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥35m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-06-30¥787m
—segment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥215m
—segment totalsegment profit2021-04-01 → 2021-06-30¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥657m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 404
ItemContextValueUnit
Other ioaPrior1YearInstant178000000JPY
Other ioaCurrentQuarterInstant181000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-6000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-7000000JPY
Investments and other assetsPrior1YearInstant4348000000JPY
Investments and other assetsCurrentQuarterInstant4416000000JPY
Noncurrent assetsPrior1YearInstant13452000000JPY
Noncurrent assetsCurrentQuarterInstant14288000000JPY
AssetsPrior1YearInstant26588000000JPY
AssetsCurrentQuarterInstant28173000000JPY
Accounts payable tradePrior1YearInstant251000000JPY
Accounts payable tradeCurrentQuarterInstant410000000JPY
Short term loans payablePrior1YearInstant3650000000JPY
Short term loans payableCurrentQuarterInstant3800000000JPY
Current portion of long term loans payablePrior1YearInstant1329000000JPY
Current portion of long term loans payableCurrentQuarterInstant1436000000JPY
Income taxes payablePrior1YearInstant356000000JPY
Income taxes payableCurrentQuarterInstant327000000JPY
Contract liabilitiesPrior1YearInstant356000000JPY
Contract liabilitiesCurrentQuarterInstant356000000JPY
Advances receivedPrior1YearInstant86000000JPY
Advances receivedCurrentQuarterInstant76000000JPY
Lease obligations clPrior1YearInstant147000000JPY
Lease obligations clCurrentQuarterInstant139000000JPY
Provision for bonusesPrior1YearInstant－JPY
Provision for bonusesCurrentQuarterInstant95000000JPY
Other clPrior1YearInstant1257000000JPY
Other clCurrentQuarterInstant1247000000JPY
Current liabilitiesPrior1YearInstant7435000000JPY
Current liabilitiesCurrentQuarterInstant7890000000JPY
Long term loans payablePrior1YearInstant7200000000JPY
Long term loans payableCurrentQuarterInstant7497000000JPY
Deferred tax liabilitiesPrior1YearInstant1000000JPY
Deferred tax liabilitiesCurrentQuarterInstant11000000JPY
Asset retirement obligations nclPrior1YearInstant149000000JPY
Asset retirement obligations nclCurrentQuarterInstant150000000JPY
Long term guarantee depositedPrior1YearInstant352000000JPY
Long term guarantee depositedCurrentQuarterInstant351000000JPY
Net defined benefit liabilityPrior1YearInstant172000000JPY
Net defined benefit liabilityCurrentQuarterInstant171000000JPY
Lease obligations nclPrior1YearInstant1067000000JPY
Lease obligations nclCurrentQuarterInstant1060000000JPY
Other nclPrior1YearInstant46000000JPY
Other nclCurrentQuarterInstant43000000JPY
Noncurrent liabilitiesPrior1YearInstant8991000000JPY
Noncurrent liabilitiesCurrentQuarterInstant9286000000JPY
LiabilitiesPrior1YearInstant16426000000JPY
LiabilitiesCurrentQuarterInstant17177000000JPY
Capital stockPrior1YearInstant3879000000JPY
Capital stockCurrentQuarterInstant3879000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass